AIDS vaccines: on the trail of two trials
Despite claims to the contrary, the present generation of AIDS vaccine candidates will in all probability be of little benefit to populations in the developing world.
The price of failure in a string of trials will be costly — the erosion of public confidence in science’s ability to deliver an effective HIV-1 vaccine.
Link to full text
Reference: Nature 415, 365 (2002)